Abstract:OBJECTIVES:To examine p53 codon 72 polymorphism in cervical cancers and its correlation with HPV16/18 E6.METHODS:Cervical specimens were taken from 81 patients with cervical squamous cancer, 18 patients with cervical adenocarcinoma, 88 patients with CIN II - III and 60 patients without cancers. PCR was used to examine the p53 genotypes and the expression of HPV16 and 18 E6.RESULTS:The frequencies of p53 Arg homozygosity in cervical squamous cancer, cervical adenocarcinoma and CIN (II - III) were 58.020%, 55.55% and 59.09% respectively, greater than those of p53 Arg/Pro heterozygosity (30.86%, 27.78%, 21.59%) and those of p53 Pro homozygosity (11.12%, 16.67%, 19.32%). The normal cervical samples also showed less frequency of p53 Arg homozygosity (23.33%) than cervical squamous cancer. There were no significant differences in the frequencies of p53 Arg homozygosity, p53 Arg/Pro heterozygosity and p53 Pro homozygosity (23.33%, 40.00% and 36.67% respectively). The frequency of HPV16,18 E6-positive in cervical cancer and CIN was much higher than that in control group (81.84%, 50.00% and 53.41%) for the normal cervical samples. The expression of HPV16 and 18 E6 in cervical squamous cancers was more frequent than in CIN. The frequency of p53 Arg homozygosity in HRHPV E6-positive cervical squamous cancers (64.06%) was greater than in HRHPV E6-negative cervical squamous cancers (35.29%) and in HRHPV E6-positive normal samples (33.33%). The p53 codon 72 polymorphism showed no differences in samples with different FIGO staging and grades.CONCLUSION:p53 Arg homozygosity could serve as a risk indicator for the tumorigenesis of cervix. In combination with HRHPV E6, it might be able to predict the progression of cervical lesions. p53 codon 72 polymorphism is not associated with FIGO staging and grades of cervical cancers.

Clinical Value of P_53 Gene Mutation in Bladder Cancer

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

The Clinical Significance of Detection of P53 Gene Mutation in Patients with Lung Cancer

EXPRESSION OF P53 PRODUCT IN CHINESE HUMAN BLADDER-CARCINOMA

[Mechanism of P53 Gene Mutation in the Development of Urologic Cancer].

Application of immunohistochemistry-laser microdissection-PCR technique in detecting p53 gene mutation in paraffin sections of gastric cancer]

[Detection of P53 Mutation Using PCR-SSCP Silver Staining Method].

Effects of plasma p53 gene mutation in the development and prognosis of non-small cell lung cancer

The Relationship Between P53 Gene Mutations and Clinicopathological Features in Glioma

[Peripheral Blood Mutated P53 DNA and Its Clinical Value in Human Breast Cancer].

[Human Papillomavirus, Human Cytomegalovirus and P53 Gene in Cervical Carcinoma].

P53 Gene Mutations in Surgical Margins with Esophageal Squamous Cell Carcinoma

[P53 Expression and Its Clinical Significance in Prostatic Carcinoma].

P53 Codon 72 Polymorphism in Cervical Cancers and Its Correlation with HPV16,18E6

[Clinical Significance of Mutant P53 Protein Expression in Lung Adenocarcinoma].

Expressions and clinical significances of PTEN and P53 gene in non-muscle-invasive bladder cancer

Expressions of p53 and hMSH2 in colon carcinoma

Clinical Biology Value of P53 Overexpression in Chinese Breast Cancer by Meta Analysis

[Alteration of P73 and P51 Genes and Its Significance in Human Gastric Carcinogenesis]